Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dezocine dose-ranging with morphine for post-thoracotomy analgesia
ChiCTR-TRC-14004661Phase 4Recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Sep 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dezocine and morphine in postoperative pain (4 arms), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoints: Morphine consumption at 1 hour postoperatively, Morphine consumption at 6 hours postoperatively and 14 more. Started Sep 2014; status: recruiting.
02
Drugs
dezocinemorphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR-TRC-14004661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004661.